| 生物活性 | Hyaluronic acid, low endotoxin (Hyaluronan, low endotoxin) is a biopolymer composed of repeating disaccharide units with low endotoxin content that is a major component of the extracellular matrix (ECM), is synthesized on the plasma membrane, exerts its effects by binding to the receptors CD44 and RHAMM, activates PI3K-Akt signaling, and enhances cell invasion and angiogenesis by promoting the binding of proteolytic MMP-9 to the cell surface or stimulating the binding of MMP-9 to the cell surface; elevated Hyaluronic acid levels are associated with tumor cell growth, adhesion, migration, invasion, and angiogenesis in digestive system cancers, and it participates in tissue remodeling and rapid cell proliferation in some physiological processes (including embryonic morphogenesis and wound healing), serves as a regulator of cancer-associated lymphangiogenesis, acts as a drug delivery vehicle for sodium butyrate to enhance its antiproliferative activity against breast cancer cell lines, lubricates the corneal endothelium, improves tissue hydration and enhances cellular resistance to mechanical damage, has been conjugated to antibodies to ensure sustained action of active compounds at sites of inflammation, and can be used in research in fields such as osteoarthritis, ophthalmology, dermatological aesthetics, tumors, and liver diseases. |
| 体外研究 (In Vitro) |
Hyaluronic acid (HA) 因其与大量水分子的结合能力而被广泛应用于美容医学。它能改善组织水合及其对机械损伤的抵抗力。HA 在伤口愈合、排卵、受精、信号转导和肿瘤生理学中起着重要作用。HA 用于治疗关节疾病,如骨关节炎或类风湿性关节炎。高分子量的 HA 可降低炎症细胞的趋化性和迁移,从而作为炎症过程的良好屏障并防止自由基的影响。HA 因其对角膜内皮的润滑特性而用于眼科,并改善美容皮肤科的组织水合和细胞对机械损伤的抵抗力,副作用很小。多项试验表明其在肿瘤标志物、肝脏疾病和药物中的作用。 |
| 性状 | 固体 |
| 颜色 | White to off-white |
| 分子式 | (C14H21NO11)n |
| CAS No. | 9004-61-9 |
| 别名 | Hyaluronan, low endotoxin; Hyaluronate, low endotoxin |
| 溶解度信息 | H2O: 14.29 mg/mL, Sonication is recommended. |
||||||||||||
| 储存方式 |
|
||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。